Published 2 September 2003. doi:10.1083/jcb.200211089
© The Rockefeller University Press,
0021-9525/2003/9/833 $5.00
The Journal of Cell Biology, Volume 162, Number 5, 833-842
Type X collagen gene regulation by Runx2 contributes directly to its hypertrophic chondrocytespecific expression in vivo
Qiping Zheng1,
Guang Zhou1,
Roy Morello1,
Yuqing Chen1,
Xavier Garcia-Rojas1 and
Brendan Lee1,2
1 Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030
2 Howard Hughes Medical Institute, Baylor College of Medicine, Houston, TX 77030
Address correspondence to Brendan Lee, Dept. of Molecular and Human Genetics Baylor College of Medicine One Baylor Plaza, Rm 635E, Houston, TX 77030. Tel.: (713) 798-8835. Fax: (713) 798-5168. email: blee{at}bcm.tmc.edu
The
1(X) collagen gene (Col10a1) is the only known hypertrophic chondrocytespecific molecular marker. Until recently, few transcriptional factors specifying its tissue-specific expression have been identified. We show here that a 4-kb murine Col10a1 promoter can drive ß-galactosidase expression in lower hypertrophic chondrocytes in transgenic mice. Comparative genomic analysis revealed multiple Runx2 (Runt domain transcription factor) binding sites within the proximal human, mouse, and chick Col10a1 promoters. In vitro transfection studies and chromatin immunoprecipitation analysis using hypertrophic MCT cells showed that Runx2 contributes to the transactivation of this promoter via its conserved Runx2 binding sites. When the 4-kb Col10a1 promoter transgene was bred onto a Runx2+/- background, the reporter was expressed at lower levels. Moreover, decreased Col10a1 expression and altered chondrocyte hypertrophy was also observed in Runx2 heterozygote mice, whereas Col10a1 was barely detectable in Runx2-null mice. Together, these data suggest that Col10a1 is a direct transcriptional target of Runx2 during chondrogenesis.
Key Words: CBFA1; COL1OA1; CCD; MCT cells; transgenic mice
Abbreviations used in this paper: CCD, cleidocranial dysplasia; EMSA, electrophoretic mobility shift assays; P1, postnatal day 1; SMCD, Schmid metaphyseal chondrodysplasia.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Kita, K., Kimura, T., Nakamura, N., Yoshikawa, H., Nakano, T.
(2008). PI3K/Akt signaling as a key regulatory pathway for chondrocyte terminal differentiation. GENES CELLS
13: 839-850
[Abstract]
[Full Text]
-
Napierala, D., Sam, K., Morello, R., Zheng, Q., Munivez, E., Shivdasani, R. A., Lee, B.
(2008). Uncoupling of chondrocyte differentiation and perichondrial mineralization underlies the skeletal dysplasia in tricho-rhino-phalangeal syndrome. Hum Mol Genet
17: 2244-2254
[Abstract]
[Full Text]
-
Wang, Q., Wei, X., Zhu, T., Zhang, M., Shen, R., Xing, L., O'Keefe, R. J., Chen, D.
(2007). Bone Morphogenetic Protein 2 Activates Smad6 Gene Transcription through Bone-specific Transcription Factor Runx2. J. Biol. Chem.
282: 10742-10748
[Abstract]
[Full Text]
-
Liu, T. M., Martina, M., Hutmacher, D. W., Hui, J. H. P., Lee, E. H., Lim, B.
(2007). Identification of Common Pathways Mediating Differentiation of Bone Marrow- and Adipose Tissue-Derived Human Mesenchymal Stem Cells into Three Mesenchymal Lineages. Stem Cells
25: 750-760
[Abstract]
[Full Text]
-
Zhou, G., Zheng, Q., Engin, F., Munivez, E., Chen, Y., Sebald, E., Krakow, D., Lee, B.
(2006). Dominance of SOX9 function over RUNX2 during skeletogenesis. Proc. Natl. Acad. Sci. USA
103: 19004-19009
[Abstract]
[Full Text]
-
Hinoi, E., Bialek, P., Chen, Y.-T., Rached, M.-T., Groner, Y., Behringer, R. R., Ornitz, D. M., Karsenty, G.
(2006). Runx2 inhibits chondrocyte proliferation and hypertrophy through its expression in the perichondrium. Genes Dev.
20: 2937-2942
[Abstract]
[Full Text]
-
Schmidl, M., Adam, N., Surmann-Schmitt, C., Hattori, T., Stock, M., Dietz, U., de Crombrugghe, B., Poschl, E., von der Mark, K.
(2006). Twisted Gastrulation Modulates Bone Morphogenetic Protein-induced Collagen II and X Expression in Chondrocytes in Vitro and in Vivo. J. Biol. Chem.
281: 31790-31800
[Abstract]
[Full Text]
-
Hirao, M., Tamai, N., Tsumaki, N., Yoshikawa, H., Myoui, A.
(2006). Oxygen Tension Regulates Chondrocyte Differentiation and Function during Endochondral Ossification. J. Biol. Chem.
281: 31079-31092
[Abstract]
[Full Text]
-
Shen, R., Wang, X., Drissi, H., Liu, F., O'Keefe, R. J., Chen, D.
(2006). Cyclin D1-Cdk4 Induce Runx2 Ubiquitination and Degradation. J. Biol. Chem.
281: 16347-16353
[Abstract]
[Full Text]
-
Shen, R., Chen, M., Wang, Y.-J., Kaneki, H., Xing, L., O'Keefe, R. J., Chen, D.
(2006). Smad6 Interacts with Runx2 and Mediates Smad Ubiquitin Regulatory Factor 1-induced Runx2 Degradation. J. Biol. Chem.
281: 3569-3576
[Abstract]
[Full Text]
-
Ijiri, K., Zerbini, L. F., Peng, H., Correa, R. G., Lu, B., Walsh, N., Zhao, Y., Taniguchi, N., Huang, X.-L., Otu, H., Wang, H., Wang, J. F., Komiya, S., Ducy, P., Rahman, M. U., Flavell, R. A., Gravallese, E. M., Oettgen, P., Libermann, T. A., Goldring, M. B.
(2005). A Novel Role for GADD45{beta} as a Mediator of MMP-13 Gene Expression during Chondrocyte Terminal Differentiation. J. Biol. Chem.
280: 38544-38555
[Abstract]
[Full Text]
-
Kang, S. K., Putnam, L., Dufour, J., Ylostalo, J., Jung, J. S., Bunnell, B. A.
(2004). Expression of Telomerase Extends the Lifespan and Enhances Osteogenic Differentiation of Adipose Tissue-Derived Stromal Cells. Stem Cells
22: 1356-1372
[Abstract]
[Full Text]
-
Qiao, M., Shapiro, P., Kumar, R., Passaniti, A.
(2004). Insulin-like Growth Factor-1 Regulates Endogenous RUNX2 Activity in Endothelial Cells through a Phosphatidylinositol 3-Kinase/ERK-dependent and Akt-independent Signaling Pathway. J. Biol. Chem.
279: 42709-42718
[Abstract]
[Full Text]
-
Smits, P., Dy, P., Mitra, S., Lefebvre, V.
(2004). Sox5 and Sox6 are needed to develop and maintain source, columnar, and hypertrophic chondrocytes in the cartilage growth plate. J. Cell Biol.
164: 747-758
[Abstract]
[Full Text]